-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TCP-25 in Epidermolysis Bullosa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TCP-25 in Epidermolysis Bullosa report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TCP-25 in Epidermolysis Bullosa Drug Details: TCP-25 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TCP-25 in Leg Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TCP-25 in Leg Ulcers report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TCP-25 in Leg Ulcers Drug Details: TCP-25 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TCP-25 in Surgical Wound Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TCP-25 in Surgical Wound Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TCP-25 in Surgical Wound Infections Drug Details: TCP-25 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RNS-60 in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RNS-60 in Acute Ischemic Stroke report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RNS-60 in Acute Ischemic Stroke Drug Details: RNS-60 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RNS-60 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RNS-60 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RNS-60 in Amyotrophic Lateral Sclerosis Drug Details: RNS-60 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TCP-25 in Surgical Wound Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TCP-25 in Surgical Wound Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TCP-25 in Surgical Wound Infections Drug Details: TCP-25 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Volixibat Potassium in Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Volixibat Potassium in Primary Biliary Cholangitis (Primary Biliary Cirrhosis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Volixibat Potassium in Primary Biliary Cholangitis (Primary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INCB-123667 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INCB-123667 in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INCB-123667 in Esophageal Cancer Drug Details: INCB-123667 is under development for the...
-
Product Insights
Hydrogels Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Hydrogels Pipeline Market Report Overview Hydrogels include dressings that consist of 96% water with a matrix of insoluble polymers embedded in it. The former helps to maintain a moist wound environment while the latter facilitates absorption of wound exudates. These dressings are available in the form of tubes and sheets and both of them are tracked under this segment. Hydrogels are segmented into antimicrobial and non-antimicrobial hydrogel dressings. The Hydrogels pipeline market research report provides comprehensive information about the Hydrogels...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PDS-0301 in Penile Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PDS-0301 in Penile CancerDrug Details:PDS-0301 (M-9241, MSB-0010360) (NHS-Interleukin-12) is under development for the treatment of metastatic...